Dapoxeodin 30 mg
Dapoxeodin is the first compound developed specially for the treatment of premature ejaculation for men between 18-64 years old. Dapoxeodin works by inhibiting the serotonin transporter, increasing serotonin’s action at the post synaptic cleft, so as to delay consequence ejaculation. As a member of selective serotonin reuptake inhibitor (SSRI) family, Dapoxeodin was initially created as an antidepressant. However, unlike other SSRIs, Dapoxeodin is absorbed and eliminated rapidly in the body. Its immediate response makes it suitable for the treatment of premature ejaculation but not as an antidepressant.
Dapoxeodin, a fast-acting serotonin reuptake transporter inhibitor, is generally prescribed for the treatment and management of premature ejaculation and erectile dysfunction in adult male.Due to the lack of specific approval treatment for premature ejaculation in the US and some other countries, other SSRIs such as Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, and Citalopram have been used as clinical drugs to treat premature ejaculation. Waldinger’s meta analysis shows that the use of these conventional antidepressants increasing IELT about 2-9 time in comparison of three to eight times when Dapoxeodin is used.
However, these SSRIs must be taken daily in order to achieve meaningful efficacy, and the long half-life increases the risk of the drug accumulation and as a consequence, an increasing adverse effects such as decreasing sexual libido and causing erectile dysfunction. Dapoxeodin, on the other hand, is a fast-acting SSRI. It is rapidly absorbed and eliminated from the body within a few hours. This favorable pharmacokinetics minimizes the risk of the drug’s accumulation in the body, and therefore reducing side effects.
For premature ejaculation and erectile dysfunctions (Adults):The recommended adult dose of Dapoxeodin is 30 – 60 mg/day. The maximum dose should not exceed 100 mg/day. Take Dapoxeodin 30 at least two hours before sexual intercourse to achieve maximum treatment benefits.
No review yet
No questions yet